EC Healthcare Announced Strategic Alliance with Prudential
EC Healthcare Announced Strategic Alliance with Prudential

HONG KONG, Feb 13, 2023 – (ACN Newswire via SEAPRWire.com) – EC Healthcare (the “Company”, which together with its subsidiaries is referred to as the “Group”, SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group formed partnership with Prudential Hong Kong Limited (“Prudential”) to jointly... » read more

Beauty Farm Medical and Health Industry Inc. Announces Proposed Listing on the Main Board of SEHK, Offer price at HK$19.32 per share

HONG KONG, Dec 30, 2022 – (ACN Newswire via SEAPRWire.com) – Beauty Farm Medical and Health Industry Inc. (“Beauty Farm” or “Company”, stock code: 2373), the largest provider of traditional beauty services in China, today announces the proposed listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited (“SEHK”).... » read more

TANAKA Contributes to Venture Capital Fund “DMC No. 1 Investment Limited Partnership” Aiming to Establish a Medical Venture Ecosystem in Japan
TANAKA Contributes to Venture Capital Fund “DMC No. 1 Investment Limited Partnership” Aiming to Establish a Medical Venture Ecosystem in Japan

TOKYO, Dec 20, 2022 – (JCN Newswire via SEAPRWire.com) – TANAKA Kikinzoku Kogyo K.K. (Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), which operates the TANAKA Precious Metals manufacturing business, announced today that it has made an equity contribution to the medical venture capital fund Diamond Medino Capital (DMC) No. 1 Investment Limited... » read more

SinoMab Awarded the “Most Valuable Pharmaceutical and Medical Company” in the Selection of the “7th Hong Kong Golden Stocks Awards”
SinoMab Awarded the “Most Valuable Pharmaceutical and Medical Company” in the Selection of the “7th Hong Kong Golden Stocks Awards”

HONG KONG, Dec 19, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that the Company... » read more

Major Global Medical Device Manufacturer OrbusNeich Medical Group Announces Details of Proposed Listing on the Main Board of HKEX
Major Global Medical Device Manufacturer OrbusNeich Medical Group Announces Details of Proposed Listing on the Main Board of HKEX

HONG KONG, Dec 13, 2022 – (ACN Newswire via SEAPRWire.com) – OrbusNeich Medical Group Holdings Limited (“OrbusNeich” or the “Group”), a major global medical device manufacturer specialized in interventional instruments for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures, has today announced the details of its proposed listing on the Main Board of... » read more

Olympus Announces Launch of Olympus Asia Pacific Innovation Program
Olympus Announces Launch of Olympus Asia Pacific Innovation Program

SINGAPORE, Dec 5, 2022 – (JCN Newswire via SEAPRWire.com) – Olympus Corporation (Olympus), a global medtech company committed to making people’s lives healthier, safer and more fulfilling, has partnered with MedTech Innovator Asia Pacific, the industry’s largest healthcare accelerator, to facilitate the Olympus Asia Pacific Innovation Program (OAIP) running throughout 2023. Over a century old,... » read more

Perfect Medical Announces Interim Results for FY2022/23

HONG KONG, Nov 23, 2022 – (ACN Newswire via SEAPRWire.com) – Perfect Medical Health Management Limited (the “Company” , Stock Code: 1830.HK), one of the largest aesthetic medical operators in the world, together with its subsidiaries (collectively referred to as the “Group”), is pleased to announce its interim results for the six months ended 30... » read more

To Develop Japan’s First Blood Biomarker-Based Diagnostic Workflow for Dementia Shimadzu, Eisai, Oita University, and Usuki City Medical Association Commence Joint Research
To Develop Japan’s First Blood Biomarker-Based Diagnostic Workflow for Dementia Shimadzu, Eisai, Oita University, and Usuki City Medical Association Commence Joint Research

TOKYO, Nov 22, 2022 – (JCN Newswire via SEAPRWire.com) – Shimadzu Corporation (Shimadzu), Eisai Co., Ltd. (Eisai), Oita University, and Usuki City Medical Association hereby announce the commencement of a cohort study using Usuki City as a demonstration site. This joint study will attempt to develop Japan’s first diagnostic workflow for mild cognitive impairment (MCI)... » read more

Society Pass (Nasdaq: SOPA)/ NusaTrip Collaborates with Periksa.id to Promote Indonesia’s Wellness, Health, and Medical Tourism Recovery Strategy
Society Pass (Nasdaq: SOPA)/ NusaTrip Collaborates with Periksa.id to Promote Indonesia’s Wellness, Health, and Medical Tourism Recovery Strategy

SINGAPORE, Nov 22, 2022 – (ACN Newswire via SEAPRWire.com) – Nusatrip, the Indonesia-based Online travel agent (OTA) and travel platform of Society Pass Incorporated (“SoPa”) (Nasdaq: SOPA), Southeast Asia’s (SEA) leading data-driven loyalty, fintech and e-commerce ecosystem, today announces an official partnership with Periksa.id, a Jakarta-based leading health-tech solutions company, to enable and introduce flight... » read more

Fujitsu and Wakayama Medical University start joint trials for millimeter-wave sensor to detect falls of elderly patients
Fujitsu and Wakayama Medical University start joint trials for millimeter-wave sensor to detect falls of elderly patients

TOKYO, Nov 21, 2022 – (JCN Newswire via SEAPRWire.com) – Fujitsu and Wakayama Medical University today announced the start of joint trials of a technology to support nurses and caregivers in visually monitoring patients in privacy-sensitive contexts, including hospital rooms and nursing facilities. The technology leverages Fujitsu’s technique for accurately estimating postures of the human... » read more

Healthcare and Medical Leaders Gather to Shape the Future of Global Health
Healthcare and Medical Leaders Gather to Shape the Future of Global Health

HONG KONG, Nov 11, 2022 – (ACN Newswire via SEAPRWire.com) – New research and innovations in Hong Kong and the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) are injecting new momentum and creating new opportunities for the regional and global healthcare and medical sectors, as highlighted in the two-day Asia Summit on Global Health (ASGH). The... » read more

Spotlight on Healthcare Collaboration and Innovation at Asia Summit on Global Health and HK International Medical and Healthcare Fair
Spotlight on Healthcare Collaboration and Innovation at Asia Summit on Global Health and HK International Medical and Healthcare Fair

HONG KONG, Nov 10, 2022 – (ACN Newswire via SEAPRWire.com) – Global healthcare collaboration and innovation are key themes of the Hong Kong Trade Development Council (HKTDC)’s inaugural International Healthcare Week, currently taking place at the Hong Kong Convention and Exhibition Centre (HKCEC). The week is comprised of two anchor events: the second Asia Summit... » read more

Led by Legend Capital, PureFDA Secures Over CNY100 million in the Series B Round
Led by Legend Capital, PureFDA Secures Over CNY100 million in the Series B Round

HONG KONG, Nov 10, 2022 – (ACN Newswire via SEAPRWire.com) – Recently, PureFDA Medical Technology (Guangzhou) Co., LTD. (hereinafter referred to as “PureFDA”) announced the completion of the Series B round of financing of over CNY100 million, which was led by Legend Capital and followed by the existing shareholder Bayland Capital. This round of funds... » read more